The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

Lifetime history of heavy cannabis use is associated with lower brain activation on working memory tasks among young adults.

Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.

The traditional Chinese practice of qigong can effectively alleviate chronic low back pain, according to study findings.

Physician burnout and intentions to reduce clinical effort or leave one’s institution are results of poor control over specific aspects of work.

There has been a large decrease in antidepressant use during pregnancy and no corresponding increase in psychotherapy claims.

Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

The US CDC has taken down multiple health-related websites and datasets, including those on HIV, LGBTQ health and more.

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

As a bird flu outbreak escalates across the US, the Trump administration has paused the release of key public health studies, stalling research that could provide insight into how the virus spreads to ...

The shutdown of HHS web pages pertaining to HIV, LGBTQ+ health, and adolescent health raises questions about the future of infectious disease monitoring and research on these topics.

Distribution of prescribed opioid analgesics is lower in majority non-White versus majority White communities across all levels of socioeconomic deprivation.